Royalty Pharma plc
DE ˙ MUN ˙ GB00BMVP7Y09
46,92 € ↑0,92 (2,01%)
2026-06-04
DEL PRIS
SecurityDE:RPD / Royalty Pharma plc
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership10,093 shares
Latest Disclosed Value $ 389,994
Group One Trading, L.p. ownership in RPD / Royalty Pharma plc

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 10,093 shares of Royalty Pharma plc (DE:RPD) valued at $331,353 USD as of December 31, 2025. The entity filed a previous 13F-HR on August 11, 2022 disclosing 0 shares of Royalty Pharma plc. The current value of the position is $473,614 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (RPD) in the form of stock options. The firm currently holds call options representing 12,300 of underlying shares valued at $475,272 USD and put options representing 21,700 of underlying shares valued at $838,488 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:RPD / Royalty Pharma plc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 10,093 10,093 390 0.0007
2022-08-11 2022-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 0 -1,602 -100.00 0 -100.00
2022-05-12 2022-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 1,602 1,602 62 0.0001
2021-08-10 2021-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 0 -1,438 -100.00 0 -100.00
2021-05-12 2021-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 1,438 1,438 63 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ROYALTY PHARMA SHS CLASS A Call 12,300 -76.57 475 -74.35 n/a n/a n/a
2025-11-12 2025-09-30 13F ROYALTY PHARMA SHS CLASS A Call 52,500 -67.47 1,852 -68.15 n/a n/a n/a
2025-08-14 2025-06-30 13F ROYALTY PHARMA SHS CLASS A Call 161,400 -21.95 5,815 -9.66 n/a n/a n/a
2025-05-14 2025-03-31 13F ROYALTY PHARMA SHS CLASS A Call 206,800 112.54 6,438 159.35 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ROYALTY PHARMA SHS CLASS A Call 97,300 86.04 2,482 67.82 n/a n/a n/a
2025-02-14 2024-12-31 13F ROYALTY PHARMA SHS CLASS A Call 97,300 2,482 n/a n/a n/a
2024-11-14 2024-09-30 13F ROYALTY PHARMA SHS CLASS A Call 52,300 41.73 1,480 52.00 n/a n/a n/a
2024-08-14 2024-06-30 13F ROYALTY PHARMA SHS CLASS A Call 36,900 -75.82 973 -79.00 n/a n/a n/a
2024-05-10 2024-03-31 13F ROYALTY PHARMA SHS CLASS A Call 152,600 38.35 4,634 49.58 n/a n/a n/a
2024-02-14 2023-12-31 13F ROYALTY PHARMA SHS CLASS A Call 110,300 -26.86 3,098 -24.29 n/a n/a n/a
2023-11-09 2023-09-30 13F ROYALTY PHARMA SHS CLASS A Call 150,800 102.14 4,093 78.46 n/a n/a n/a
2023-08-09 2023-06-30 13F ROYALTY PHARMA SHS CLASS A Call 74,600 -3.37 2,293 -17.55 n/a n/a n/a
2023-05-12 2023-03-31 13F ROYALTY PHARMA SHS CLASS A Call 77,200 115.04 2,782 96.12 n/a n/a n/a
2023-02-09 2022-12-31 13F ROYALTY PHARMA SHS CLASS A Call 35,900 27.30 1,419 25.15 n/a n/a n/a
2022-11-09 2022-09-30 13F ROYALTY PHARMA SHS CLASS A Call 28,200 540.91 1,133 512.43 n/a n/a n/a
2022-08-11 2022-06-30 13F ROYALTY PHARMA SHS CLASS A Call 4,400 -27.87 185 -22.27 n/a n/a n/a
2022-05-12 2022-03-31 13F ROYALTY PHARMA SHS CLASS A Call 6,100 -74.04 238 -74.57 n/a n/a n/a
2022-02-11 2021-12-31 13F ROYALTY PHARMA SHS CLASS A Call 23,500 -8.56 936 0.75 n/a n/a n/a
2021-11-12 2021-09-30 13F ROYALTY PHARMA SHS CLASS A Call 25,700 142.45 929 114.06 n/a n/a n/a
2021-08-10 2021-06-30 13F ROYALTY PHARMA SHS CLASS A Call 10,600 -16.54 434 -21.66 n/a n/a n/a
2021-05-12 2021-03-31 13F ROYALTY PHARMA SHS CLASS A Call 12,700 139.62 554 109.06 n/a n/a n/a
2021-02-10 2020-12-31 13F ROYALTY PHARMA SHS CLASS A Call 5,300 307.69 265 381.82 n/a n/a n/a
2020-11-12 2020-09-30 13F ROYALTY PHARMA SHS CL A Call 1,300 55 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ROYALTY PHARMA SHS CLASS A Put 21,700 214.49 838 244.86 n/a n/a n/a
2025-11-12 2025-09-30 13F ROYALTY PHARMA SHS CLASS A Put 6,900 -83.84 243 -84.20 n/a n/a n/a
2025-08-14 2025-06-30 13F ROYALTY PHARMA SHS CLASS A Put 42,700 -68.39 1,538 -63.42 n/a n/a n/a
2025-05-14 2025-03-31 13F ROYALTY PHARMA SHS CLASS A Put 135,100 4,206 n/a n/a n/a
2024-08-14 2024-06-30 13F ROYALTY PHARMA SHS CLASS A Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-10 2024-03-31 13F ROYALTY PHARMA SHS CLASS A Put 10,000 -75.00 304 -73.02 n/a n/a n/a
2024-02-14 2023-12-31 13F ROYALTY PHARMA SHS CLASS A Put 40,000 32.89 1,124 37.62 n/a n/a n/a
2023-11-09 2023-09-30 13F ROYALTY PHARMA SHS CLASS A Put 30,100 183.96 817 151.08 n/a n/a n/a
2023-08-09 2023-06-30 13F ROYALTY PHARMA SHS CLASS A Put 10,600 5,200.00 326 4,542.86 n/a n/a n/a
2023-05-12 2023-03-31 13F ROYALTY PHARMA SHS CLASS A Put 200 7 n/a n/a n/a
2022-08-11 2022-06-30 13F ROYALTY PHARMA SHS CLASS A Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-12 2022-03-31 13F ROYALTY PHARMA SHS CLASS A Put 1,300 -27.78 51 -29.17 n/a n/a n/a
2022-02-11 2021-12-31 13F ROYALTY PHARMA SHS CLASS A Put 1,800 -60.00 72 -55.83 n/a n/a n/a
2021-11-12 2021-09-30 13F ROYALTY PHARMA SHS CLASS A Put 4,500 45.16 163 28.35 n/a n/a n/a
2021-08-10 2021-06-30 13F ROYALTY PHARMA SHS CLASS A Put 3,100 47.62 127 38.04 n/a n/a n/a
2021-05-12 2021-03-31 13F ROYALTY PHARMA SHS CLASS A Put 2,100 425.00 92 360.00 n/a n/a n/a
2021-02-10 2020-12-31 13F ROYALTY PHARMA SHS CLASS A Put 400 -55.56 20 -47.37 n/a n/a n/a
2020-11-12 2020-09-30 13F ROYALTY PHARMA SHS CL A Put 900 38 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.